Who’s Your Daddy? Pfizer Partnership…In Canada!

[anonymous]

HLS Therapeutics Announces Promotional Agreement with Pfizer for Vascepa® in Canada

• Agreement enables rapid, efficient and impactful expansion to the primary care physician audience.
• HLS will continue to focus primarily on specialists while Pfizer will focus primarily on primary care physicians.
• Pfizer is a well-respected partner with a shared passion for innovation in Cardiology and a rich heritage in the space.

 

[anonymous]

Big Pharma is the only way to maximize Vascepa’s potential. The new CEO sees what a failure the US Sales Force is. News on the US hopefully shortly.

 

[anonymous]

So this looks like a testing ground for Pfizer. If Vascepa performs well in primary care offices in Canada, they are a sure bit to purchase Amarin in the future!

 

[anonymous]

So this looks like a testing ground for Pfizer. If Vascepa performs well in primary care offices in Canada, they are a sure bit to purchase Amarin in the future!

Looks like a sign to Hikma to settle or be wiped out with a Pfizer combo pill

 

[anonymous]

What could this mean for US Vascepa market? Buy out from Pfizer?

 

[anonymous]

What could this mean for US Vascepa market? Buy out from Pfizer?

Wow. Another Amarin rocket scientist. Yes, you dope.